NANCY HALE: Open Payments
NPI 1790735306 · BARDSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 30 payments from 13 companies in 2025. Trend: 2023 $1,087 · 2024 $629 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| ABBVIE INC. | 5 | $109 |
| PFIZER INC. | 4 | $65 |
| Amgen Inc. | 4 | $57 |
| Novo Nordisk Inc | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Averitas Pharma Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $21 |
Products named: VRAYLAR, FARXIGA, OTEZLA, PREVNAR 20, AIRSUPRA, CAPLYTA, UBRELVY, QUTENZA.
Industry payments across KY — which companies pay providers there.
